CIK 0001101026 · Non-accelerated filer<br>Smaller reporting company
Zivo Bioscience, Inc.
Sign in to watch- Ticker
- ZIVO
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 870699977
- Phone
- (248) 452 9866
- Business address
- 21 E. LONG LAKE ROAD, SUITE 100, BLOOMFIELD HILLS, MI, 48304
- Former names
- HEALTH ENHANCEMENT PRODUCTS INC, WESTERN GLORY HOLE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-04 | RICE II PHILIP M Chief Financial Officer | Grant or award · Common Stock Purchase Option | +2,000,000 | 2,000,000 | ||
| 2020-01-22 | Maggiore Christopher D. Director | Purchase | +24,000 | $0.15 | $4K | 40,704,122 |
| 2020-01-16 | Maggiore Christopher D. Director | Purchase | +20,000 | $0.16 | $3K | 40,680,122 |
| 2020-01-15 | Maggiore Christopher D. Director | Purchase | +16,000 | $0.16 | $3K | 40,660,122 |
| 2020-01-10 | Maggiore Christopher D. Director | Purchase | +5,000 | $0.16 | $800 | 40,644,122 |
| 2020-01-03 | Maggiore Christopher D. Director | Purchase | +5,000 | $0.16 | $800 | 40,639,122 |
| 2019-12-30 | Maggiore Christopher D. Director | Purchase | +50,000 | $0.16 | $8K | 40,634,122 |
| 2019-12-26 | Maggiore Christopher D. Director | Purchase | +65,000 | $0.16 | $10K | 40,584,122 |
| 2019-12-24 | Maggiore Christopher D. Director | Purchase | +50,000 | $0.16 | $8K | 40,519,122 |
| 2019-12-23 | Maggiore Christopher D. Director | Purchase | +225,125 | $0.14 | $32K | 40,469,122 |
| 2019-12-19 | Maggiore Christopher D. Director | Purchase | +95,000 | $0.12 | $11K | 40,243,997 |
| 2019-12-18 | Maggiore Christopher D. Director | Purchase | +125,000 | $0.12 | $15K | 40,148,997 |
| 2019-12-17 | Maggiore Christopher D. Director | Purchase | +65,500 | $0.11 | $7K | 40,023,997 |
| 2019-12-16 | Maggiore Christopher D. Director | Purchase | +117,500 | $0.12 | $14K | 39,958,497 |
| 2019-12-13 | Maggiore Christopher D. Director | Purchase | +30,000 | $0.12 | $4K | 39,840,997 |
| 2019-12-10 | Maggiore Christopher D. Director | Purchase | +205,000 | $0.13 | $27K | 39,810,997 |
| 2019-12-09 | Maggiore Christopher D. Director | Purchase | +64,000 | $0.13 | $8K | 39,605,997 |
| 2019-12-06 | DAHL ANDREW A President/CEO | Grant or award · Common Stock Purchase Option | +1,000,000 | 1,000,000 | ||
| 2019-12-06 | Maggiore Christopher D. Director | Purchase | +61,522 | $0.12 | $7K | 39,541,997 |
| 2019-12-05 | Maggiore Christopher D. Director | Purchase | +115,000 | $0.11 | $13K | 39,480,475 |
Page 9 of 12 · 228 trades